Spectrum Asset Management Inc. NB CA Trims Stock Position in Linde PLC $LIN
Spectrum Asset Management Inc. NB CA significantly reduced its stake in Linde PLC by 45.1% in Q4, selling 3,876 shares and holding 4,714 shares valued at $2.01 million. Despite this reduction by one investor, other institutional investors have increased their positions in Linde, and Wall Street analysts generally maintain a "Buy" rating for the stock with an average price target of $521.60. Linde also reported strong Q4 earnings, surpassing analyst estimates, and increased its quarterly dividend.
Citizens Financial Likely To Report Higher Q1 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Citizens Financial Group (NYSE: CFG) is anticipated to report increased first-quarter earnings and revenue when it releases results before the market opens on Thursday, April 16. Analysts expect earnings per share of $1.08, up from $0.77 year-over-year, and revenue of $2.15 billion. Several analysts from firms like JP Morgan, Evercore ISI Group, and Morgan Stanley have recently updated their ratings and price targets for CFG stock.
Morgan Stanley raises BlackRock stock price target on growth outlook
Morgan Stanley has increased its price target for BlackRock (NYSE:BLK) stock to $1,393 from $1,368, maintaining an Overweight rating. This decision is based on an outlook for mid-single-digit organic revenue growth and operating margin expansion, driven by structural tailwinds such as private market democratization and technology monetization. The firm projects a 15% EPS compound annual growth rate from 2025-2028, noting that BlackRock trades at a discount despite its superior growth profile.
J. M. Smucker (NYSE:SJM) Rating Increased to Strong-Buy at BTIG Research
BTIG Research upgraded J. M. Smucker (NYSE:SJM) to a "strong-buy" rating. This upgrade comes amidst other recent analyst adjustments, with the stock currently holding a "Moderate Buy" consensus rating and a target price of $117.94. The company recently reported strong earnings, beating consensus estimates, and institution investors have also been active in the stock.
São Paulo hotel performance jumped for Design Week
São Paulo's hotel industry experienced a significant boost in March 2026, largely due to Design Week, achieving record-high ADR and RevPAR. Occupancy increased by 13% to 67.8%, and ADR rose by 7.4% to BRL871.48, with peak performance on March 11. Other events like Capacity LATAM, ST Alphe Brazil, and the WST Skateboarding World Championship also contributed to strong results throughout the month.
Aurora Cannabis Buys Safari Flower to Boost EU GMP Supply for Global Medical Markets
Aurora Cannabis (TSE:ACB) has acquired Safari Flower Company for $26.5 million, adding an EU GMP certified cultivation facility to its network. This acquisition aims to expand Aurora's EU GMP capacity for international medical markets and is expected to contribute positively to Adjusted EBITDA from fiscal 2027. The deal strengthens Aurora's position in high-margin global medical cannabis markets and supports its strategy to capture greater international market share.
EQT (NYSE:EQT) Lowered to Hold Rating by Citigroup
Citigroup downgraded EQT (NYSE:EQT) from a "strong-buy" to a "hold" rating, as reported by Zacks.com. This comes amidst varied analyst opinions, with several firms reiterating "buy" or "outperform" ratings and target price adjustments. The article also details EQT's recent stock performance, earnings, insider transactions, and institutional investor activity, alongside key news impacting the company.
Arista Networks (NYSE:ANET) Upgraded at Zacks Research
Zacks Research has upgraded Arista Networks (NYSE:ANET) from a "hold" to a "strong-buy" rating. This upgrade is supported by other analysts who have also issued "overweight" or "buy" ratings with price targets ranging from $165.00 to $200.00. The company's recent strong earnings performance and its pivotal role in AI infrastructure are highlighted as key drivers for this positive outlook.
INCY Reiterates by HC Wainwright & Co. -- Price Target Maintained at $135
HC Wainwright & Co. has reiterated a Buy rating for Incyte (INCY), maintaining a price target of $135.00, signaling confidence in the biopharmaceutical company's growth potential. GuruFocus assesses INCY as 1.1% undervalued with a strong GF Score™ of 93/100, driven by exceptional financial strength and profitability. Despite recent insider selling, the stock presents a solid investment opportunity due to its undervaluation and robust financials.
Prairiewood Capital LLC Purchases 56,465 Shares of Ares Capital Corporation $ARCC
Prairiewood Capital LLC increased its stake in Ares Capital Corporation (NASDAQ:ARCC) by 22.9% in the 4th quarter, purchasing an additional 56,465 shares, bringing its total holdings to 303,282 shares valued at $6.135 million. The article also details other institutional investor activity, Ares Capital's stock performance, recent earnings, dividend announcement, and insider trading by company executives. Analyst ratings for ARCC are mixed, with an average "Moderate Buy" rating and a price target of $21.38.



